Purpose: To investigate whether diabetes mellitus is correlated with tear film dysfunction. Methods: Tear film function tests including tear film breakup time (BUT), fluorescein staining, Schirmer I test, rose Bengal staining, total tear protein detection, tear sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and TMS-4 corneal topography were performed. A dry-eye questionnaire was used. Results: Compared with the control group and nonproliferative diabetic retinopathy (NPDR) group, in the proliferative diabetic retinopathy (PDR) group, the BUT and the value of the Schirmer I test were reduced significantly (p < 0.01); corneal fluorescein staining scores, the positive rate of rose Bengal staining and the surface regularity index (SRI) and surface asymmetry index (SAI) were higher (p < 0.01); concentrations of lactoferrin and tear-specific prealbumin were lower (p < 0.01, p < 0.05, respectively). In diabetic patients, the SRI and SAI were positively correlated with fluorescein staining scores (r = 0.754, 0.480, p < 0.01, respectively), and the dry-eye symptoms were significantly related to an abnormal BUT and Schirmer I test (p < 0.01, respectively). Conclusion: The declined tear film function is severer in the patients with PDR than in those with NPDR. Besides the traditional methods, tear SDS-PAGE and TMS corneal topographic indices contribute to the discovery of tear film dysfunction in diabetic patients.

Keywords:
Diabetes mellitus, Tear film function, Diabetic retinopathy
1.
Dogru M, Katakami C, Inoue M: Tear function and ocular surface changes in noninsulin dependent diabetes mellitus. Ophthalmology 2001;108:586–592.
2.
Good KL, Maggs DJ, Hollingsworth SR, Scagliotti RH, Nelson RW: Corneal sensitivity in dogs with diabetes mellitus. Am J Vet Res 2003;64:7–11.
3.
Sanchez-Thorin JC: The cornea in diabetes mellitus. Int Ophthalmol Clin 1998;38:19–36.
4.
Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T: Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea 2001;20:798–801.
5.
Stolwijk TR, van Best JA, Lemkes HH, de Keizer RJ, Oosterhuis JA: Determination of basal tear turnover in insulin-dependent diabetes mellitus patients by fluorophotometry. Int Ophthalmol 1991;15:377–382.
6.
Goebbels M: Tear secretion and tear film function in insulin dependent diabetes. Br J Ophthalmol 2000;84:19–21.
7.
Kaiserman I, Kaiserman N, Nakar S, Vinker S: Dry eye in diabetic patients. Am J Ophthalmol 2005;139:498–503.
8.
Lemp MA: Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J 1995;21:221–232.
9.
Nepp J, Abela C, Polzer I, Derbolav A, Wedrich A: Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca. Cornea 2000;19:487–491.
10.
Grus FH, Augustin AJ, Evangelou NG, Toth-Sagi K: Analysis of tear protein patterns as a diagnostic tool for the detection of dry eyes. Eur J Ophthalmol 1998;8:90–97
11.
De Paiva CS, Lindsey JL, Pflugfelder SC: Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology 2003;110:1102–1109.
12.
Liu Z, Pflugfelder SC: Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999;106:939–943.
13.
Holly FJ: Diagnosis and treatment of dry eyes in the United States. 1st International Tear Film Symposium. Lubbock, Dry Eye Institute, 1984, pp 299–305.
14.
Gobbels M: The dry eye: status determination and prospects. Fortschr Ophthalmol 1990;87(suppl):S190–S197.
15.
Bjerrum KB: The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjögren’s syndrome. Acta Ophthalmol Scand 1997;75:505–511.
16.
Grus FH, Sabuncuo P, Dick HB, Augustin AJ, Pfeiffer N: Changes in the tear proteins of diabetic patients. BMC Ophthalmol 2002; 2:4.
17.
Ng V, Cho P, To C: Tear proteins of normal young Hong Kong Chinese. Graefes Arch Clin Exp Ophthalmol 2000;238:738–745.
18.
Stolwijk TR, Kuizenga A, van Haeringen NJ, Kijlstra A, Oosterhuis JA, van Best JA: Analysis of tear fluid proteins in insulin dependent diabetes mellitus. Acta Ophthalmol (Copenh) 1994;72:357–362.
19.
Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T: Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea 2001;20:798–801.
20.
Dogru M, Katakami C, Inoue M: Tear function and ocular surface changes in noninsulin dependent diabetes mellitus. Ophthalmology 2001;108:586–592.
21.
Wilson SE, Klyee SD: Advances in the analysis of corneal topography: a clinical study. Arch Ophthalmol 1991;109:349–353.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.